Professional Documents
Culture Documents
Updated Corona Virus Protection - 4
Updated Corona Virus Protection - 4
Allianz EFU Health Insurance Coronavirus (COVID-19) is a respiratory illness caused by a new
Limited virus. Symptoms range from a mild cough to pneumonia. Some
D-136, Block-4 KDA Scheme-5 people recover easily, others may get very sick very quickly.
Clifton Karachi-75600, Pakistan There is evidence that it spreads from person to person. Good
hygiene can prevent infection.
CORONAVIRUS (COVID 19)
Symptoms of COVID-19 may appear in as few as 2 days or as long as 14 days after exposure.
If you develop emergency warning signs for COVID-19 get medical attention immediately. Emergency warning signs
include*:
*This list is not all inclusive. Please consult your medical provider for any other symptoms that are severe or concerning.
• The majority of people (around 80%) have asymptomatic to moderate disease and recover without needing hospital
treatment
• Around 15% may get severe disease including pneumonia
Older people and those with underlying medical problems such as high blood pressure, heart and lung
problems, diabetes, or cancer are more likely to develop serious illness
Around 5% become critically unwell. This may include septic shock and/or multi-organ and respiratory
failure
The infection fatality rate (the proportion of deaths among all infected individuals) is estimated to be 0.9% but it varies
according to age and sex. It is lower in younger people (0.5% for those 45-64 years) and higher in those over 75 years of age
(11.6%)
CORONAVIRUS (COVID 19)
• venous thromboembolism
• heart, liver and kidney problems
• neurological problems
• coagulation (blood clotting) failure
• respiratory failure
• multiple organ failure
• septic shock
Social Distancing
Social distancing includes ways to stop or slow the spread of infectious diseases. It means less contact between you and other
people.
Social distancing is important because COVID-19 is most likely to spread from person-to-person through:
Direct close contact with a person while they are infectious or in the 24 hours before their symptoms appeared
Close contact with a person with a confirmed infection who coughs or sneezes, or
Touching objects or surfaces (such as door handles or tables) contaminated from a cough or sneeze from a person
with a confirmed infection, and then touching your mouth or face.
So, the more space between you and others, the harder it is for the virus to spread.
Encourage flexible working arrangements including working from home and off-peak travel, and consider whether
staff work stations can be more widely spaced.
Purchase COVID-19 prevention supplies, for example alcohol hand sanitizers
Provide and promote hand sanitizers at building entrances.
Stay at home if you are sick
Stop handshaking as a greeting
Hold meetings via video conferencing or phone call
Defer large meetings
Hold essential meetings outside in the open air if possible
Encourage personal hygiene, such as use of hand sanitizer or hand washing with soap by all staff.
Take lunch at your desk or outside rather than in the lunch room
Clean and disinfect high touch surfaces regularly
Consider opening windows and adjusting air conditioning for more ventilation
Limit food handling and sharing of food in the workplace
Reconsider non-essential business travel
Promote strictest hygiene among food preparation (canteen) staff and their close contacts
Consider if large gatherings can be rescheduled, staggered or cancelled
Hospital is place where chance of exposure of different infections is very high especially infection likes COVID 19.
It is suggested do not visit hospitals until unless medically necessary, try to limit visiting sick people, consider
whether you can postpone planned surgery or elective procedure except it requires emergency care.
Events where a large number of people are in one place can increase the risk of transmission of viruses. If you are
organizing a gathering, consider whether you can postpone or cancel the event. If you decide to go ahead, you should
assess the risks and reconsider any aspect that may increase risk of transmission.
CORONAVIRUS (COVID 19)
Who is at Risk
In Pakistan, the people most at risk of getting the virus are those who have:
Recently been in COVID-19 affected area
Been in close contact with someone who is a confirmed case of coronavirus
Based on what we know about coronaviruses, those most at risk of serious infection are:
people with compromised immune systems (such as people who have cancer)
elderly people
people with chronic medical conditions
people in group residential settings
You will only be tested if your doctor decides you meet the criteria:
You have returned from overseas in the past 14 days and you develop respiratory illness with or without fever
You have been in close contact with a confirmed COVID-19 case in the past 14 days and you develop respiratory
illness with or without fever
You have severe community-acquired pneumonia and there is no clear cause
You are a healthcare worker who works directly with patients and you have a respiratory illness and a fever
CORONAVIRUS (COVID 19)
After testing
It may take a few days for the test results to come back. If you have serious symptoms you will be kept in hospital and
isolated from other patients to prevent the virus spreading.
If your doctor says you are well enough to go home while you wait for your test results, you should:
your symptoms
any travel history
any recent contact with someone who has COVID-19
Treatment
There is no specific antiviral treatment recommended for COVID-19. People with COVID-19 should receive supportive care
to help relieve symptoms. For severe cases, treatment should include care to support vital organ functions
• Take pain and fever medications (Caution: do not give aspirin to children)
• Use a room humidifier or take a hot shower to help ease a sore throat and cough
• Drink plenty of liquids
• Stay home and rest
Treatment includes symptomatic treatment for fever, cough, I/V Fluids, Oxygen if needed and other measures to keep patient
comfortable.
Fear of Disease
The rise in COVID-19 infections and deaths during the third wave is most likely due to the spread of the UK and South
African virus variants in Pakistan, a new study has revealed. The situation may slip out of control if immediate measures are
not taken to address the looming disaster. The study revealed that around 50% of the new infections are of the UK variants
while 25% are South African variants. Due to large-scale violations of coronavirus SOPs in Pakistan, these variants have the
potential to infect a large proportion of the population within a short period. There is an urgent need to increase genomic
surveillance of the coronavirus to contain rapidly emerging new strains.
Another newly-identified coronavirus variant is also causing a surge of infections in India. The variant, known as B.1.617,
has experts worried because of its “double mutation”. It has two mutations in the virus spike protein that might make it easier
to escape immune responses as well as spread faster. Patients with typical severe COVID-19 symptoms are testing negative
even using the latest RT-PCR-based assays
COVID-19 VACCINE
To understand how COVID-19 vaccines work, it helps to first look at how our bodies fight illness. When germs, such as the
virus that causes COVID-19, invade our bodies, they attack and multiply. This invasion, called an infection, is what causes
illness. Our immune system uses several tools to fight infection. Blood contains red cells, which carry oxygen to tissues and
organs, and white or immune cells, which fight infection. Different types of white blood cells fight infection in different
ways:
Macrophages are white blood cells that swallow up and digest germs and dead or dying cells. The macrophages
leave behind parts of the invading germs, called “antigens”. The body identifies antigens as dangerous and stimulates
antibodies to attack them.
B-lymphocytes are defensive white blood cells. They produce antibodies that attack the pieces of the virus left
behind by the macrophages.
T-lymphocytes are another type of defensive white blood cell. They attack cells in the body that have already been
infected.
The first time a person is infected with the virus that causes COVID-19, it can take several days or weeks for their body to
make and use all the germ-fighting tools needed to get over the infection. After the infection, the person’s immune system
remembers what it learned about how to protect the body against that disease.
CORONAVIRUS (COVID 19)
The body keeps a few T-lymphocytes, called “memory cells”, that go into action quickly if the body encounters the same
virus again. When the familiar antigens are detected, B-lymphocytes produce antibodies to attack them. Experts are still
learning how long these memory cells protect a person against the virus that causes COVID-19.
COVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the
illness.
Different types of vaccines work in different ways to offer protection. But with all types of vaccines, the body is left with a
supply of “memory” T-lymphocytes as well as B-lymphocytes that will remember how to fight that virus in the future.
It typically takes a few weeks after vaccination for the body to produce T-lymphocytes and B-lymphocytes. Therefore, it is
possible that a person could be infected with the virus that causes COVID-19 just before or just after vaccination and then get
sick because the vaccine did not have enough time to provide protection.
Sometimes after vaccination, the process of building immunity can cause symptoms, such as fever. These symptoms are
normal and are signs that the body is building immunity.
Types of Vaccines
Below is a description of how each type of vaccine prompts our bodies to recognize and protect us from the virus that causes
COVID-19. None of these vaccines can give you COVID-19.
mRNA vaccines The Pfizer-BioNtech and Moderna vaccines both are mRNA vaccines, which work differently
than many other types of vaccines. mRNA vaccines train your immune system to make antibodies for specific
diseases without injecting the virus into your body.
Typically, vaccines work by injecting a tiny part of a virus called an antigen into your body. This type of vaccine is
called a live attenuated vaccine. The amount injected is not enough to make you sick, but it makes your immune
system create cells called antibodies that can fight that particular antigen. Then, if your body experiences the antigen
again, it will remember it and quickly produce more antibodies to defend itself.
Instead, mRNA vaccines use messenger RNA, a piece of genetic code that tells our cells what to do, like make new
proteins or repair damage. mRNA is naturally found in all of our cells, but in 2005, infectious disease experts at Penn
Medicine discovered how to modify mRNA to safely make our cells create proteins similar to those found in some
viruses. Once those proteins are made, our immune systems can then create antibodies for that virus
Protein subunit vaccines Protein subunit vaccines work by injecting only small pieces of the COVID-19 virus that
best stimulate your immune system, rather than the whole germ.
These COVID vaccines include spike proteins (S proteins) that your immune system recognizes as not belonging in
your body. It then creates antibodies, so your body remembers the virus and can fight COVID-19 if you become
infected in the future.
Novavax is currently developing a protein subunit vaccine for COVID-19, which entered a large-scale clinical trial
on Dec. 28, 2020.
CORONAVIRUS (COVID 19)
Vector vaccines contain a modified version of a different virus than the one that causes COVID-19. Inside the shell
of the modified virus, there is material from the virus that causes COVID-19. This is called a “viral vector.” Once the
viral vector is inside our cells, the genetic material gives cells instructions to make a protein that is unique to the
virus that causes COVID-19. Using these instructions, our cells make copies of the protein. This prompts our bodies
to build T-lymphocytes and B-lymphocytes that will remember how to fight that virus if we are infected in the future.
The Johnson & Johnson, AstaZeneca, Sputnic V and CansinoBio vaccines are vector vaccines
Whole Virus Vaccine The whole virus vaccine uses a weakened or deactivated form of the pathogen that causes
COVID-19 to trigger protective immunity to it.
The two vaccines Sinopharm and Sinovac – both use inactivated pathogens, therefore they cannot infect cells and
replicate, but can trigger an immune response.
Vaccine interchangeability
Data is not yet available on the interchangeability of different COVID-19 vaccines. Therefore, every effort should be made to
determine which vaccine the individual received and to complete with the same vaccine.
Yes! Similar to other vaccines, a large number of people in the community will need to get vaccinated before transmission
drops enough to stop the use of masks.
CORONAVIRUS (COVID 19)
https://allianzefu.com/xls/covidfile.xls
Please note that hospitals servicing Covid-19 patients continue to change. Details on hospitals servicing Covid-19 patients in
a region may kindly be sought from Allianz EFU 24/7 Medical Hotlines.
NOTE: OMI Hospital has made a protocol that each and every patient who needs admission in any condition is to be kept in
isolation for 2 days or until his or her COVID-19 test results are known. Those patients who will have a negative result will
be able to shift to a regular room or ward.
A routine admission with general medical condition or for surgical needs, except COVID-19 effected patients seeking
hospital admission, is not recommended for OMI hospital. If patients with a negative COVID-19 (till the result come) are
kept in an isolation/quarantine facility wherein patients with possible COVID-19 results are also being kept, the risk of
contracting virus increases manifold.
The following are some important points to consider before being admitted to the hospital.
● It has been observed that COVID-19 service providers are changing each passing day. Some panel hospitals are
offering services for COVID-19 patients, however, when healthcare workers working in a hospital get infected, the
hospital stops servicing COVID-19 patients.
● The Government has defined a protocol for hospitals whereby the Government or DHO must be reported of any
patient who is admitted for the management of COVID-19. Likewise, as per defined protocols, COVID-19 test will
be repeated after the patient is admitted in hospital's isolation ward for 14 days. Discharge of the patient will be
processed only after the test result is negative. This means a patient, once admitted for treatment of COVID-19, will
remain hospitalized for more than 14 days.
● The average cost of treatment of a COVID-19 patient, under hospitalization, is approximately PKR 100,000 per day
without ventilator support; whereas a patient seeking ventilator support will be booking a daily expense of
approximately PKR 150,000. In such cases, the cost of a 14-day hospitalization can range from PKR 1 million to
PKR 2 million. This is an approximate cost of treatment, which may increase if the patient is admitted for more than
14 days in complicated COVID-19 disease.
● Considering the high cost of treatment, a few hospitals have also developed a protocol for such admissions, which
requires a minimum cash deposit or insurance approval of PKR 1 million. For these hospitals, if this amount is not
deposited before admission, the patient’s admission is not processed by the hospital. In such cases, the insurance
company will approve up to the patient's available Hospitalization Limit whereas, in line with the hospital’s policy,
the remaining over and above amount will have to be paid by the patient before admission.
● Insurance companies have been informed by hospitals that soon after discharge of the patient, the bill will be
dispatched immediately and the hospitals are seeking settlement of their bills within seven days of receiving the bill.
In such cases, any amount over and above the available hospitalization limit of the patient shall have to be borne by
the patient himself.
Dr. Ziauddin Hospital, Karachi is charging insurance companies 30 percent higher cost than the cost charged to private
patients. Considering this an additional burden on the clients, we have decided not to cover admissions in this hospital on
credit.